Evaluation of donor demographic, clinical, and serological characteristics in COVID convalescent plasma donation by plasmapheresis

Evaluation of donor demographic, clinical, and serological characteristics in COVID convalescent plasma donation by plasmapheresis

Background and Objectives: Passive transfusion of convalescent plasma (CCP) in coronavirus disease 2019 (COVID-19) has proven to be a winning and logistically feasible therapeutic strategy. The efficacy of plasma depends on appropriate donor screening and selection. Ours being a tertiary care hospit...

Full description

Bibliographic Details
Main Authors:	Sudipta Sekhar Das, Rathindra Nath Biswas, Rafique uz Zaman, Subrata Sen
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Global Journal of Transfusion Medicine
Subjects:	antibody anti-severe acute respiratory syndrome coronavirus 2 coronavirus disease 2019 donor screening plasmapheresis
Online Access:	http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2021;volume=6;issue=2;spage=198;epage=204;aulast=Das

Similar Items

Harvesting COVID convalescent plasma using latest-generation apheresis systems: Analyzing factors associated with donor, machine, and manufactured product
by: Sudipta Sekhar Das, et al.
Published: (2021-01-01)

The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial
by: Morten Haugen, et al.
Published: (2024-03-01)

Prospects of plasmapheresis for patients with severe COVID-19
by: Ilmira R. Gilmutdinova, et al.
Published: (2020-09-01)

Plasmapheresis in the Treatment of Refractory Myoclonic Status. A Case Report
by: Gutierrez-Gutierrez Judit, et al.
Published: (2021-10-01)

The risks of low hemoglobin deferral in a large retrospective cohort of plasmapheresis donors and the influence factors of return for a subsequent donation in China
by: Guanglin Xiao, et al.
Published: (2023-03-01)

The impact of educating blood donors on plasmapheresis and plasma applications on the availability of plasma-derived medicinal products
by: Jakub Sutkowski, et al.
Published: (2023-02-01)

Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern India
by: Sudipta Sekhar Das, et al.
Published: (2021-01-01)

Seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 antibody among healthy blood donors in a hospital-based blood center in Eastern India during the COVID-19 pandemic
by: Sudipta Sekhar Das, et al.
Published: (2022-01-01)

Analysis of changes in pre- and post-donation hematological parameters among plateletpheresis donors at SKIMS blood bank: A hospital-based study
by: Imran Khurshid, et al.
Published: (2020-01-01)

Discrete plasmapheresis for coronary heart disease
by: I N Solov'eva, et al.
Published: (2014-08-01)

Serological evaluation and differentiation of subgroups of “A” and “AB” in healthy blood donor population in Eastern India
by: Sudipta Sekhar Das, et al.
Published: (2020-01-01)

Assessment of Standard Operating Procedures (SOPs) Preparing Hygienic Condition in the Blood Donation Centers during the Outbreak of COVID-19
by: Saeed Mohammadi, et al.
Published: (2023-07-01)

Source Plasma Donation: The Experience of the Iranian Blood Transfusion Organization
by: Saeed Mohammadi, et al.
Published: (2022-07-01)

Plasmapheresis in the ICU
by: Guleid Hussein, et al.
Published: (2023-12-01)

Live kidney donor with a history of COVID-19 infection: When to go for transplant? - A case report
by: Hari Shankar Meshram, et al.
Published: (2021-01-01)

TRADITIONAL AND CASCADE PLASMAPHERESIS IN ANTIBODY TITERS’ REDUCTION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01)

Issues faced by a resource-constrained stem cell donor registry and impact of coronavirus disease 2019 on their functioning: A 9-year observational study from a single registry in India
by: Hina Solanki, et al.
Published: (2022-01-01)

Hypertriglyceridemia Induced Pancreatitis Treated with Medical Management without Plasmapheresis
by: Ushna Naveed, et al.
Published: (2021-06-01)

Therapeutic Plasmapheresis: Seven Year Experience of an Intensive Care Unit in Portugal
by: Rita Faria, et al.
Published: (2022-03-01)

FEATURES OF PLASMAPHERESIS IN THE TREATMENT OF GRAFT REJECTION AFTER KIDNEY TRANSPLANTATION
by: A. V. Vatazin, et al.
Published: (2015-10-01)

Plasmapheresis as a treatment of thyrotoxicosis in pregnancy: Case report
by: Michele Obeid, et al.
Published: (2022-06-01)

Comparison of safety and efficacy of convalescent plasma with fresh frozen plasma in severe covid-19 patients
by: MEENU BAJPAI, et al.
Published: (2022-09-01)

Assessing the impetus and impediments to donate coronavirus disease-2019 convalescent plasma: A survey study from a tertiary care Indian blood center
by: Manish Raturi, et al.
Published: (2022-01-01)

An alternative treatment in hypertriglyceridemia-induced acute pancreatitis in pregnancy: Plasmapheresis
by: Dilek Altun, et al.
Published: (2012-01-01)

Outcomes of COVID‐19–Positive Donor Heart Transplantation in the United States
by: Samuel T. Kim, et al.
Published: (2023-07-01)

Plasmapheresis for a Patient with Catatonia and Systemic Lupus Erythematosus: A Case Report and Literature Review
by: Pei-Shan Tsai, et al.
Published: (2022-11-01)

Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study
by: Li Huang, et al.
Published: (2021-08-01)

Plasmapheresis for Extrapontine Myelinolysis: A Case Series and a Literature Review
by: Devasmitha Wijesundara, et al.
Published: (2022-02-01)

Use of convalescent plasma therapy in eight individuals with mild COVID-19
by: F. Ji, et al.
Published: (2021-01-01)

Severe L-asparaginase-induced Hypertriglyceridaemia Treated with Plasmapheresis
by: José Silvano, et al.
Published: (2021-02-01)

Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis
by: Diego Curtò, et al.
Published: (2021-06-01)

Plasmapheresis-Induced Hypercalcaemia
by: Anas-Alwogud Abdelmogheth, et al.
Published: (2013-02-01)

One Year Outcomes Following Transplantation with COVID-19-Positive Donor Hearts: A National Database Cohort Study
by: Stanley B. Wolfe, et al.
Published: (2024-01-01)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
by: Daniele Focosi, et al.
Published: (2022-05-01)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
by: Gil C. De Santis, et al.
Published: (2022-03-01)

Approach for Safe Transfusion Practices during COVID-19 Pandemic: Observation of an Indian Rural Blood Bank
by: Nikhil, et al.
Published: (2022-05-01)

Alloimmunization to erythrocyte antigens in patients receiving multiple blood transfusions: Clinico-immunohematological and demographic risk factors and impact of extended red cell phenotyping
by: Sudipta Sekhar Das, et al.
Published: (2021-01-01)

Determinants of quality of life changes with plasmapheresis in patients with myasthenia gravis
by: Ibraheim Al-Ahmer, et al.
Published: (2021-05-01)

Medication and Plasmapheresis Efficacy in Bronchial Asthma Combined with Arterial Hypertension
by: T.V. Stepanova, et al.
Published: (2009-06-01)

Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
by: Jing Ouyang, et al.
Published: (2020-09-01)